All Stories

  1. Long-term postpartum adherence to antiretroviral drugs among women in Latin America
  2. Raltegravir Pharmacokinetics During Pregnancy
  3. Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries
  4. Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study
  5. Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life
  6. Reduced indinavir exposure during pregnancy
  7. Squamous intraepithelial lesions in HIV-infected women: prevalence, incidence, progression and regression
  8. Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy
  9. Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection
  10. Antiretroviral Adherence During Pregnancy and Postpartum in Latin America
  11. Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts
  12. Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection
  13. Safety and efficacy of contraceptive implants for HIV-infected women in Porto Alegre, Brazil
  14. Mode of delivery and neonatal respiratory morbidity among HIV-exposed newborns in Latin America and the Caribbean: NISDI Perinatal-LILAC Studies
  15. Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
  16. Response to ‘Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients’ by Mariné-Barjoan et al.